Readable research linked to original sources

Articles

Browse normalized, publication-ready research with direct links to its evidence and source.

2 articles

Newest first

Research Article 2025CC BYFree full text

The use of endoscopic ultrasound in tandem with endoscopic retrograde cholangiopancreatography in the 2019 American Society for Gastrointestinal Endoscopy guideline for patients at high risk of choledocholithiasis can help to avoid diagnostic endoscopic retrograde cholangiopancreatography in individuals without ascending cholangitis.

Apichet Sirinawasatien, Jiravit Chanchairungcharoen, Thanapon Yaowmaneerat, Jirat Jiratham‐opas, Kanokpoj Chanpiwat, Tanyaporn Chantarojanasiri +4 more

Objectives Choledocholithiasis is the leading cause of biliary pancreatitis and biliary sepsis. Endoscopic retrograde cholangiopancreatography (ERCP) is considered a minimally invasive treatment for choledocholithiasis. However, diagnostic ERCP should be avoided. We conducted a prospective trial in high-risk choledocholithiasis patients based on the American Society for Gastrointestinal Endoscopy (ASGE) 2019 crite…

DEN Open Europe PMC

Open article record in new tab ↗

Research Article 2016CC BY-NC-SAFree full text · non-commercial reuse

Comparing cost-effectiveness between endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in diagnosis of common bile duct stone in patients with predefined risks: A study from a developing country.

Nisa Netinatsunton, Siriboon Attasaranya, Jaksin Sottisuporn, Teepawit Witeerungrot, Theeratus Jongboonyanuparp, Teerha Piratvisuth +1 more

Background and objectives Endoscopic ultrasound (EUS) achieves results comparable to endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of common bile duct (CBD) stone, but studies from the western have shown EUS to be less expensive in patients with intermediate risk for CBD stones. The aim of this study was to compare the costs of EUS and ERCP in the diagnosis of CBD stones in a developing co…